Patents by Inventor Eamon Mulvaney

Eamon Mulvaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thromboxane receptor antagonist formulations
    Patent number: 12708607
    Abstract: The present invention provides formulations that enhances bioavailability of thromboxane receptor antagonists allowing them to bind to the thromboxane A2 receptors in subjects suffering from disease indications in which the prostanoid thromboxane A2, and incidental thromboxane A2 receptor ligands, are implicated. The formulations comprise a solid dispersion comprising a benzenesulfonyl urea and a polymer that are suitable for administration through oral or other routes of delivery.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: August 18, 2026
    Assignee: ATXA THERAPEUTICS LIMITED
    Inventors: B. Therese Kinsella, Helen Reid, Eamon Mulvaney
  • THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS
    Publication number: 20230301946
    Abstract: The present invention provides formulations that enhances bioavailability of thromboxane receptor antagonists allowing them to bind to the thromboxane A2 receptors in subjects suffering from disease indications in which the prostanoid thromboxane A2, and incidental thromboxane A2 receptor ligands, are implicated. The formulations comprise a solid dispersion comprising a benzenesulfonyl urea and a polymer that are suitable for administration through oral or other routes of delivery.
    Type: Application
    Filed: July 6, 2021
    Publication date: September 28, 2023
    Inventors: B. Therese Kinsella, Helen Reid, Eamon Mulvaney